Table 2.
Day 60 model | Day 90 model | Day 120 model | |
Antihyperlipidemics | |||
β0 (intercept) | 7.195 | 11.791 | 16.462 |
β1 (MPR) | −8.850 | −14.481 | −20.350 |
β2 (age) | −0.039 | −0.034 | −0.031 |
Antihypertensives | |||
β0 (intercept) | 5.911 | 10.430 | 14.397 |
β1 (MPR) | −8.140 | −13.420 | −18.260 |
β2 (age) | −0.031 | −0.029 | −0.027 |
Oral hypoglycemics | |||
β0 (intercept) | 6.406 | 10.759 | 14.524 |
β1 (MPR) | −8.436 | −13.595 | −18.260 |
β2 (age) | −0.031 | −0.029 | −0.026 |
MPR, medication possession ratio.